VITAmin and Micronutrient Testing: Acceptability and SCOPE of Point-of-care Device
NCT ID: NCT06882421
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2024-06-25
2024-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight
NCT02383329
Micronutrients in Children in Critical Care With Cardiac Conditions
NCT02409706
the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children
NCT05911893
Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain
NCT03944161
Effects of Oral Nutritional Supplementation in Children at Risk of Undernutrition
NCT05239208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently micronutrient measurement is performed in hospitals. A large volume (\>6mls) is taken with results for some tests taking a minimum of 2 weeks. This delays treatment starting and requires provision of additional clinical time for the results to be fed back to patients and their families. There are significant financial, emotional and carbon costs for patients attending for hospital based blood tests.
A point-of-care blood test for micronutrients has been developed, which uses an integrated finger-prick and minimal amount of blood (40μls). The device is simple to use, with just one push of a button, allowing primary care clinicians and potentially parents/guardians to administer the test.
This study aims to ask young people and their parents/carers for their views on this device before further development is undertaken on the product to ensure it meets with their needs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parents/Participants must have capacity to consent/assent and provide a signed and dated informed consent
* Able to participate in an interview regarding the acceptability/usability of the device.
Exclusion Criteria
1 Year
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of East Anglia
OTHER
Norfolk and Norwich University Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emma Webb, PhD
Role: PRINCIPAL_INVESTIGATOR
Consultant at NNUH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich, Norfolk, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
62431
Identifier Type: REGISTRY
Identifier Source: secondary_id
Version 1.2 03/06/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.